FDA will hold public hearings on March 25-26 at its White Oak, MD campus on a plan to strengthen its oversight of OTC products and align it more closely with the prescription drug process. Comments will be accepted until May 12, 2014.
[membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
